Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
95.34 BRL | +18.14% | -0.06% | +52.62% |
06-14 | Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy | RE |
06-14 | Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup | DJ |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- NOVO B Stock
- N1VO34 Stock
- Revisions Novo Nordisk A/S